Genetics of Sarcoidosis

Clinics in Chest Medicine

Volumn 29, Issue 3, 2008, Pages 391-414

  Müller Quernheim, Joachim ^a   Schürmann, Manfred ^b   Hofmann, Sylvia ^c   Gaede, Karoline I ^d   Fischer, Annegret ^c   Prasse, Antje ^a   Zissel, Gernot ^a   Schreiber, Stefan ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d RESEARCH CENTER BORSTEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN; PROSTAGLANDIN SYNTHASE;

BERYLLIOSIS; BLAU SYNDROME; CROHN DISEASE; ENVIRONMENTAL EXPLOITATION; GENETIC LINKAGE; GENETICS; GRANULOMA; HUMAN; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK; SARCOIDOSIS; WEGENER GRANULOMATOSIS;

CHEMOKINES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; RISK FACTORS; SARCOIDOSIS;

EID: 44649173145     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2008.03.007     Document Type: Review

References (207)

1. American Thoracic Society. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS), and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160 2 (1999) 736-755
2. Müller-Quernheim J. Sarcoidosis: immunopathogenetic concepts and their clinical application. Eur Respir J 12 3 (1998) 716-738
3. Iannuzzi M.C., Rybicki B.A., and Teirstein A.S. Sarcoidosis. N Engl J Med 357 21 (2007) 2153-2165
4. Zissel G., Prasse A., and Muller-Quernheim J. Sarcoidosis-immunopathogenetic concepts. Semin Respir Crit Care Med 28 1 (2007) 3-14
5. Teirstein A.S., and Lesser M. Worldwide distribution and epidemiology of sarcoidosis. In: Fanburg B. (Ed). Sarcoidosis and other granulomatous diseases of the lung (1983), Dekker, Basel (Switzerland) 101-134
6. Hillerdal G., Nöu E., Osterman K., et al. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 130 (1984) 29-32
7. Rybicki B.A., Major M., Popovich Jr. J., et al. Racial differences in sarcoidosis incidence: a 5-year study in health maintenance organization. Am J Epidemiol 145 (1997) 234-241
8. Edmondstone W.M., and Wilson A.G. Sarcoidosis in Caucasians, blacks and Asians in London. Br J Dis Chest 79 1 (1985) 27-36
9. James D.G., Neville E., and Siltzbach L.E. A worldwide review of sarcoidosis. Ann N Y Acad Sci 278 (1976) 321-334
10. Baughman R.P., Teirstein A.S., Judson M.A., et al. Clinical characteristics of patients in a case-control study of sarcoidosis. Am J Respir Crit Care Med 164 10 Pt 1 (2001) 1885-1889
11. Berlin M., Fogdell-Hahn A., Olerup O., et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 156 5 (1997) 1601-1605
12. Maná J., Gomez-Vaquero C., Montero A., et al. Löfgren's syndrome revisited: a study of 186 patients. Am J Med 107 3 (1999) 240-245
13. Rose C.S., Martyny J.W., Newman L.S., et al. Lifeguard lung: endemic granulomatous pneumonitis in an indoor swimming pool. Am J Public Health 88 12 (1998) 1795-1800
14. Newman L.S., Mroz M.M., Balkissoon R., et al. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med 171 1 (2005) 54-60
15. Müller-Quernheim J., Gaede K.I., Fireman E., et al. Diagnoses of chronic beryllium disease within cohorts of sarcoidosis patients. Eur Respir J 27 (2006) 1190-1195
16. Richeldi L., Sorrentino R., and Saltini C. HLA-DPB 1 glutamate 69: a genetic marker of beryllium disease. Science 262 (1993) 242-244
17. Newman L.S. Metals that cause sarcoidosis. Semin Respir Infect 13 3 (1998) 212-220
18. Rafnsson V., Ingimarsson O., Hjalmarsson I., et al. Association between exposure to crystalline silica and risk of sarcoidosis. Occup Environ Med 55 10 (1998) 657-660
19. Newman L.S. Beryllium disease and sarcoidosis: clinical and laboratory links. Sarcoidosis 12 (1995) 7-19
20. Iannuzzi M.C., and Rybicki B.A. Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc 4 1 (2007) 108-116
21. Spagnolo P., and du Bois R.M. Genetics of sarcoidosis. Clin Dermatol 25 3 (2007) 242-249
22. Jörgensen G. Die Genetik der Sarkoidose. Acta Medica Scandinavica 425 Suppl (1964) 209-212
23. Kirsten D. [Sarcoidosis in Germany. Analysis of a questionnaire survey in 1992 of patients of the German Sarcoidosis Group]. Pneumologie 49 6 (1995) 378-382 [in German]
24. Wirnsberger R.M., de Vries J., Wouters E.F., et al. Clinical presentation of sarcoidosis in the Netherlands: an epidemiological study. Neth J Med 53 2 (1998) 53-60
25. McGrath D.S., Daniil Z., Foley P., et al. Epidemiology of familial sarcoidosis in the UK. Thorax 55 9 (2000) 751-754
26. McGrath D.S., Goh N., Foley P.J., et al. Sarcoidosis: genes and microbes-soil or seed?. Sarcoidosis Vasc Diffuse Lung Dis 18 2 (2001) 149-164
27. Fite E., Alsina J.M., Anto J.M., et al. Sarcoidosis: family contact study. Respiration 65 1 (1998) 34-39
28. Rybicki B.A., Harrington D., Major M., et al. Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol 13 1 (1996) 23-33
29. Rybicki B.A., Iannuzzi M.C., Frederick M.M., et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164 11 (2001) 2085-2091
30. Sellei J., and Berger M. Sarkoidos Geschwülste in einer Falmilie. Archiv für Dermatologie und Syphilis (Wien) 150 (1926) 47-51
31. Wiman L.G. Familial occurrence of sarcoidosis. Scand J Respir Dis Suppl 80 (1972) 115-119
32. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 447 7145 (2007) 661-678
33. Tromp G., Kuivaniemi H., Raphael S., et al. Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am J Hum Genet 59 5 (1996) 1097-1107
34. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379 6568 (1996) 821-823
35. Rybicki B.A., Maliarik M.J., Bock C.H., et al. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16 2 (1999) 203-208
36. Hampe J., Cuthbert A., Croucher P.J., et al. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357 9272 (2001) 1925-1928
37. Miceli-Richard C., Lesage S., Rybojad M., et al. CARD15 mutations in Blau syndrome. Nat Genet 29 1 (2001) 19-20
38. Schürmann M., Valentonyte R., Hampe J., et al. CARD15 gene mutations in sarcoidosis. Eur Respir J 22 5 (2003) 748-754
39. Moller E., Hedfors E., and Wiman L.G. HL-A genotypes and MLR in familial sarcoidosis. Tissue Antigens 4 4 (1974) 299-305
40. Schürmann M., Lympany P.A., Reichel P., et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 861-864
41. Valentonyte R., Hampe J., Huse K., et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37 4 (2005) 357-364
42. Iannuzzi M.C., Iyengar S.K., Gray-McGuire C., et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 6 6 (2005) 509-518
43. Schürmann M., Reichel P., Müller-Myhsok B., et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 164 5 (2001) 840-846
44. Gray-McGuire C., Sinha R., Iyengar S., et al. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet 120 3 (2006) 420-430
45. Rybicki B.A., Sinha R., Iyengar S., et al. Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study. Genes Immun 8 5 (2007) 379-386
46. Thompson C.L., Rybicki B.A., Iannuzzi M.C., et al. Reduction of sample heterogeneity through use of population substructure: an example from a population of African American families with sarcoidosis. Am J Hum Genet 79 4 (2006) 606-613
47. Judson M.A., Hirst K., Iyengar S.K., et al. Comparison of sarcoidosis phenotypes among affected African American siblings. Chest 130 3 (2006) 855-862
48. Valentonyte R., Hampe J., Croucher P.J., et al. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med 171 10 (2005) 1136-1141
49. Pasturenzi L., Martinetti M., Cuccia M., et al., Group tP-PSS. HLA class I, II, and III polymorphism in Italian patients with sarcoidosis. Chest 104 (1993) 1170-1175
50. Ishihara M., Ohno S., Ishida T., et al. Analysis of allelic variation of the TAP2 gene in sarcoidosis. Tissue Antigens 49 2 (1997) 107-110
51. Ishihara M., Ohno S., Mizuki N., et al. Genetic polymorphisms of the major histocompatibility complex-encoded antigen-processing genes TAP and LMP in sarcoidosis. Hum Immunol 45 2 (1996) 105-110
52. Foley P.J., Lympany P.A., Puscinska E., et al. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis. Am J Respir Crit Care Med 160 3 (1999) 1009-1014
53. Brewerton D.A., Cockburn C., James D.C., et al. HLA antigens in sarcoidosis. Clin Exp Immunol 27 2 (1977) 227-229
54. Smith M.J., Turton C.W., Mitchell D.N., et al. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax 36 4 (1981) 296-298
55. Dubaniewicz A., Szczerkowska Z., and Hoppe A. Comparative analysis of HLA class I antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin Proc 78 4 (2003) 436-442
56. Hedfors E., and Lindstrom F. HLA-B8/DR3 in sarcoidosis. Correlation to acute-onset disease with arthritis. Tissue Antigens 22 3 (1983) 200-203
57. Lio D., Candore G., Romano G.C., et al. Modification of cytokine patterns in subjects bearing the HLA-B8,DR3 phenotype: implications for autoimmunity. Cytokines Cell Mol Ther 3 4 (1997) 217-224
58. Grunewald J., Eklund A., and Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 169 6 (2004) 696-702
59. Bogunia-Kubik K., Tomeczko J., Suchnicki K., et al. DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57 1 (2001) 87-90
60. Rutherford R.M., Brutsche M.H., Kearns M., et al. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 21 3 (2004) 191-198
61. Naruse T.K., Matsuzawa Y., Ota M., et al. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 56 1 (2000) 52-57
62. Schürmann M., Bein G., Kirsten D., et al. HLA-DQB1 and HLA-DPB1 genotypes in familial sarcoidosis. Respir Med 92 (1998) 649-652
63. Voorter C.E., Drent M., and van den Berg-Loonen E.M. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101. Hum Immunol 66 7 (2005) 826-835
64. Rossman M.D., Thompson B., Frederick M., et al. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73 4 (2003) 720-735
65. Voorter C.E., Drent M., Hoitsma E., et al. Association of HLA DQB1 0602 in sarcoidosis patients with small fiber neuropathy. Sarcoidosis Vasc Diffuse Lung Dis 22 2 (2005) 129-132
66. Sato H., Grutters J.C., Pantelidis P., et al. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 27 4 (2002) 406-412
67. Grunewald J., Olerup O., Persson U., et al. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc Natl Acad Sci USA 91 11 (1994) 4965-4969
68. Grunewald J., and Eklund A. Sex-specific manifestations of Löfgren's syndrome. Am J Respir Crit Care Med 175 1 (2007) 40-44
69. Foley P.J., McGrath D.S., Puscinska E., et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 25 3 (2001) 272-277
70. Voorter C.E., Amicosante M., Berretta F., et al. HLA class II amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens 70 1 (2007) 18-27
71. Wang Z., White P.S., Petrovic M., et al. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol 163 3 (1999) 1647-1653
72. Lombardi G., Germain C., Uren J., et al. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J Immunol 166 5 (2001) 3549-3555
73. Maliarik M.J., Chen K.M., Major M.L., et al. Analysis of HLA-DPB1 polymorphisms in African Americans with sarcoidosis. Am J Respir Crit Care Med 158 1 (1998) 111-114
74. Nguyen T., Liu X.K., Zhang Y., et al. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. J Immunol 176 12 (2006) 7354-7360
75. Rybicki B.A., Walewski J.L., Maliarik M.J., et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and whites. Am J Hum Genet 77 3 (2005) 491-499
76. Spagnolo P., Sato H., Grutters J.C., et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens 70 3 (2007) 219-227
77. Toews G.B., Vial W.C., Dunn M.M., et al. The accessory cell function of human alveolar macrophages in specific T cell proliferation. J Immunol 132 1 (1984) 181-186
78. Zissel G., Ernst M., Schlaak M., et al. Accessory function of alveolar macrophages from patients with sarcoidosis and other granulomatous and nongranulomatous lung diseases. J Investig Med 45 2 (1997) 75-86
79. Nicod L.P., and Isler P. Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L. Am J Respir Cell Mol Biol 17 1 (1997) 91-96
80. Ziegenhagen M.W., and Muller-Quernheim J. The cytokine network in sarcoidosis and its clinical relevance. J Intern Med 253 1 (2003) 18-30
81. Zissel G., Homolka J., Schlaak J., et al. Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Respir Crit Care Med 154 (1996) 713-719
82. El-Gamel A., Awad M.R., Hasleton P.S., et al. Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. J Heart Lung Transplant 18 6 (1999) 517-523
83. Ludviksson B.R., and Gunnlaugsdottir B. Transforming growth factor-beta as a regulator of site-specific T-cell inflammatory response. Scand J Immunol 58 2 (2003) 129-138
84. Muraközy G., Gaede K.I., Zissel G., et al. Analysis of gene polymorphisms in interleukin-10 and transforming growth factor-beta 1 in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18 2 (2001) 165-169
85. Jonth A.C., Silveira L., Fingerlin T.E., et al. TGF-beta1 variants in chronic beryllium disease and sarcoidosis. J Immunol 179 6 (2007) 4255-4262
86. Awad M.R., El-Gamel A., Hasleton P., et al. Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung Transplantation. Transplantation 66 8 (1998) 1014-1020
87. Kruit A., Grutters J.C., Ruven H.J., et al. Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 129 6 (2006) 1584-1591
88. Bohnert A., Schurmann M., Hartung A., et al. No linkage of the interleukin-4 receptor locus on chromosome 16p11.2-12.1 with sarcoidosis in German multiplex families. Eur J Immunogenet 29 3 (2002) 269-272
89. Kelly D.M., Greene C.M., Meachery G., et al. Endotoxin up-regulates interleukin-18: potential role for gram-negative colonization in sarcoidosis. Am J Respir Crit Care Med 172 10 (2005) 1299-1307
90. Janssen R., Grutters J.C., Ruven H.J., et al. No association between interleukin-18 gene polymorphisms and haplotypes in Dutch sarcoidosis patients. Tissue Antigens 63 6 (2004) 578-583
91. Takada T., Suzuki E., Morohashi K., et al. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population. Tissue Antigens 60 1 (2002) 36-42
92. Zhou Y., Yamaguchi E., Hizawa N., et al. Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 22 2 (2005) 105-113
93. Müller-Quernheim J., Pfeifer S., Mannel D., et al. Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 145 1 (1992) 187-192
94. Ziegenhagen M.W., Rothe M.E., Zissel G., et al. Exaggerated TNF-alpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 19 3 (2002) 185-190
95. Bendtzen K., Morling N., Fomsgaard A., et al. Association between HLA-DR2 and production of tumour necrosis factor alpha and interleukin 1 by mononuclear cells activated by lipopolysaccharide. Scand J Immunol 28 5 (1988) 599-606
96. Jacob C.O., Fronek Z., Lewis G.D., et al. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87 3 (1990) 1233-1237
97. McGuire W., Hill A., Allsopp C., et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 371 (1994) 508-511
98. Cabrera M., Shaw M.A., Sharples C., et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182 5 (1995) 1259-1264
99. Huang S.L., Su C.H., and Chang S.C. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis. Am J Respir Crit Care Med 156 5 (1997) 1436-1439
100. Lee Y.H., Ji J.D., and Song G.G. Tumor necrosis factor-alpha promoter -308 A/G polymorphism and rheumatoid arthritis susceptibility: a meta-analysis. J Rheumatol 34 1 (2007) 43-49
101. Lee Y.H., Rho Y.H., Choi S.J., et al. Association of TNF-alpha -308 G/A polymorphism with responsiveness to TNF-alpha blockers in rheumatoid arthritis: a meta-analysis. Rheumatol Int 27 2 (2006) 157-161
102. Seitzer U., Swider C., Stüber F., et al. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokines 9 10 (1997) 787-790
103. Somoskövi A., Zissel G., Seitzer U., et al. Polymorphism at position -308 in the promotor region of the TNF-alpha and in the first intron o the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis. Cytokines 11 11 (1999) 882-887
104. Ziegenhagen M.W., Benner U.K., Zissel G., et al. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med 156 5 (1997) 1586-1592
105. Idali F., Wiken M., Wahlstrom J., et al. Reduced Th1 response in the lungs of HLA-DRB1*0301 patients with pulmonary sarcoidosis. Eur Respir J 27 3 (2006) 451-459
106. Swider C., Schnittger L., Bogunia-Kubik K., et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 10 2 (1999) 143-146
107. Seitzer U., Gerdes J., and Müller-Quernheim J. Evidence for disease phenotype associated haplotypes (DR.TNF) in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18 3 (2001) 279-283
108. Grutters J.C., Sato H., Pantelidis P., et al. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 165 8 (2002) 1119-1124
109. Spagnolo P., Renzoni E.A., Wells A.U., et al. C-C chemokine receptor 5 gene variants in relation to lung disease in sarcoidosis. Am J Respir Crit Care Med 172 6 (2005) 721-728
110. Petrek M., Drabek J., Kolek V., et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162 3 Pt 1 (2000) 1000-1003
111. Hizawa N., Yamaguchi E., Furuya K., et al. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 159 6 (1999) 2021-2023
112. Spagnolo P., Renzoni E.A., Wells A.U., et al. C-C chemokine receptor 2 and sarcoidosis: association with Lofgren's syndrome. Am J Respir Crit Care Med 168 10 (2003) 1162-1166
113. Pabst S., Baumgarten G., Stremmel A., et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 143 3 (2006) 420-426
114. Veltkamp M., Grutters J.C., van Moorsel C.H., et al. Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients. Clin Exp Immunol 145 2 (2006) 215-218
115. Veltkamp M., Wijnen P.A., van Moorsel C.H., et al. Linkage between Toll-like receptor (TLR) 2 promotor and intron polymorphisms: functional effects and relevance to sarcoidosis. Clin Exp Immunol 149 3 (2007) 453-462
116. Schürmann M., Kwiatkowski R., Albrecht M., et al. Study of Toll-like receptor gene loci in sarcoidosis. Clin Exp Immunol (2008) submitted for publication
117. Fan C., Nylander P.O., Sikstrom C., et al. Orosomucoid and haptoglobin types in patients with sarcoidosis. Exp Clin Immunogenet 12 1 (1995) 31-35
118. Yamazaki K., McGovern D., Ragoussis J., et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14 22 (2005) 3499-3506
119. Drent M., van den Berg R., Haenen G.R., et al. NF-kappaB activation in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 18 1 (2001) 50-56
120. Petkova D.K., Clelland C.A., Ronan J.E., et al. Reduced expression of cyclooxygenase (COX) in idiopathic pulmonary fibrosis and sarcoidosis. Histopathology 43 4 (2003) 381-386
121. Hill M.R., Papafili A., Booth H., et al. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 174 8 (2006) 915-922
122. Abel L., Sanchez F.O., Oberti J., et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 177 1 (1998) 133-145
123. Bellamy R. Identifying genetic susceptibility factors for tuberculosis in Africans: a combined approach using a candidate gene study and a genome-wide screen. Clin Sci (Lond) 98 3 (2000) 245-250
124. Maliarik M.J., Chen K.M., Sheffer R.G., et al. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol 22 6 (2000) 672-675
125. Dubaniewicz A., Jamieson S.E., Dubaniewicz-Wybieralska M., et al. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland. Eur J Hum Genet 13 7 (2005) 829-834
126. Biller H., Zissel G., Ruprecht B., et al. Genotype-corrected reference values for serum angiotensin-converting enzyme. Eur Respir J 28 6 (2006) 1085-1090
127. Ziegenhagen M.W., Rothe M.E., Schlaak M., et al. Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 21 3 (2003) 407-413
128. Gilbert S., Steinbrech D.S., Landas S.K., et al. Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 148 (1993) 483-486
129. Sharma P., Smith I., Maguire G., et al. Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 349 (1997) 1602-1603
130. Furuya K., Yamaguchi E., Itoh A., et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 51 8 (1996) 777-780
131. Planck A., Eklund A., Yamaguchi E., et al. Angiotensin-converting enzyme gene polymorphism in relation to HLA-DR in sarcoidosis. J Intern Med 251 3 (2002) 217-222
132. McGrath D.S., Foley P.J., Petrek M., et al. Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med 164 2 (2001) 197-201
133. Tomita H., Ina Y., Sugiura Y., et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis. Am J Respir Crit Care Med 156 (1997) 255-259
134. Arbustini E., Grasso M., Leo G., et al. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 153 (1996) 851-854
135. Medica I., Kastrin A., Maver A., et al. Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J Hum Genet 52 10 (2007) 836-847
136. Pietinalho A., Furuya K., Yamaguchi E., et al. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 13 4 (1999) 723-726
137. Papadopoulos K.I., Melander O., Orho-Melander M., et al. Angiotensin-converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 247 1 (2000) 71-77
138. Alia P., Mana J., Capdevila O., et al. Association between ACE gene I/D polymorphism and clinical presentation and prognosis of sarcoidosis. Scand J Clin Lab Invest 65 8 (2005) 691-697
139. Schürmann M., Reichel P., Müller-Myhsok B., et al. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 249 1 (2001) 77-83
140. Maliarik M.J., Rybicki B.A., Malvitz E., et al. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 158 5 Pt 1 (1998) 1566-1570
141. Biller H, Gaede KI, Ruprecht B, et al. Genepolymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis. Mol Med, Submitted for publication.
142. Kruit A., Grutters J.C., Gerritsen W.B., et al. ACE I/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis. Respir Med 101 3 (2007) 510-515
143. Kruit A., Ruven H.J., Grutters J.C., et al. Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 22 3 (2005) 195-203
144. Li Y., Wollnik B., Pabst S., et al. BTNL2 gene variant and sarcoidosis. Thorax 61 3 (2006) 273-274
145. Baughman R.P., Lower E.E., and du Bois R.M. Sarcoidosis. Lancet 361 9363 (2003) 1111-1118
146. Judson M.A., Thompson B.W., Rabin D.L., et al. The diagnostic pathway to sarcoidosis. Chest 123 2 (2003) 406-412
147. Löfgren S. Primary pulmonary sarcoidosis. Acta Med Scand 145 (1953) 424-465
148. Iannuzzi M.C., and Baughman R.P. Reverse phenotyping in sarcoidosis. Am J Respir Crit Care Med 175 1 (2007) 4-5
149. Drent M., Wirnsberger R.M., de Vries J., et al. Association of fatigue with an acute-phase response in sarcoidosis. Eur Respir J 13 4 (1999) 718-722
150. Prasse A., Katic C., Germann M., et al. Phenotyping sarcoidosis from the pulmonary perspective. Am J Respir Crit Care Med 177 3 (2008) 330-336
151. Sugisaki K., Yamaguchi T., Nagai S., et al. Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 20 3 (2003) 222-226
152. Judson M.A., Baughman R.P., Thompson B.W., et al. Two-year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 20 3 (2003) 204-211
153. Wasfi Y.S., Rose C.S., Murphy J.R., et al. A new tool to assess sarcoidosis severity. Chest 129 5 (2006) 1234-1245
154. Scadding J. Sarcoidosis (1967), Eyre & Spottiswoode, London
155. Maier L., Martyny J., Mroz M., et al. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease. Chest 121 3 Suppl (2002) 81S
156. Newman L.S., Lloyd J., and Daniloff E. The natural history of beryllium sensitization and chronic beryllium disease. Environ Health Perspect 104S 5 (1996) 937-943
157. Rossman M.D., Stubbs J., Lee C.W., et al. Human leukocyte antigen class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity. Am J Respir Crit Care Med 165 6 (2002) 788-794
158. Saltini C., Richeldi L., Losi M., et al. Major histocompatibility locus genetic markers of beryllium sensitization and disease. Eur Respir J 18 4 (2001) 677-684
159. Richeldi L., Kreiss K., Mroz M.M., et al. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 32 4 (1997) 337-340
160. McCanlies E.C., Ensey J.S., Schuler C.R., et al. The association between HLA-DPB1Glu69 and chronic beryllium disease and beryllium sensitization. Am J Ind Med 46 2 (2004) 95-103
161. Maier L.A., McGrath D.S., Sato H., et al. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol 171 12 (2003) 6910-6918
162. Amicosante M., Sanarico N., Berretta F., et al. Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta69. Hum Immunol 62 7 (2001) 686-693
163. Saltini C., Winestock K., Kirby M., et al. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N Engl J Med 320 (1989) 1103-1109
164. Fontenot A.P., Canavera S.J., Gharavi L., et al. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease. J Clin Invest 110 10 (2002) 1473-1482
165. Amicosante M., Berretta F., Franchi A., et al. HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells. Eur Respir J 20 5 (2002) 1174-1178
166. Tinkle S.S., and Newman L.S. Beryllium-stimulated release of tumor necrosis factor-alpha, interleukin-6, and their soluble receptors in chronic beryllium disease. Am J Respir Crit Care Med 156 6 (1997) 1884-1891
167. Bost T., Newman L., and Riches D. Increased TNF-alpha and IL6 mRNA expression by alveolar macrophages in chronic beryllium disease. Chest 103 2 Suppl (1993) 138S
168. Maier L.A., Sawyer R.T., Bauer R.A., et al. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med 164 7 (2001) 1192-1199
169. Gaede K.I., Amicosante M., Schurmann M., et al. Function-associated transforming growth factor-beta gene polymorphism in chronic beryllium disease. J Mol Med 83 5 (2005) 397-405
170. Sato H., Silveira L., Fingerlin T., et al. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol 119 3 (2007) 687-696
171. McCanlies E.C., Schuler C.R., Kreiss K., et al. TNF-alpha polymorphisms in chronic beryllium disease and beryllium sensitization. J Occup Environ Med 49 4 (2007) 446-452
172. Newman L.S., Orton R., and Kreiss K. Serum angiotensin-converting enzyme activity in chronic beryllium disease. Am Rev Respir Dis 146 1 (1992) 39-42
173. Maier L.A., Raynolds M.V., Young D.A., et al. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med 159 4 Pt 1 (1999) 1342-1350
174. Blau E.B. Familial granulomatous arthritis, iritis, and rash. J Pediatr 107 5 (1985) 689-693
175. Becker M.L., and Rose C.D. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep 7 6 (2005) 427-433
176. Kanazawa N., Okafuji I., Kambe N., et al. Early onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105 3 (2005) 1195-1197
177. Milman N., Hoffmann A.L., and Byg K.E. Sarcoidosis in children. Epidemiology in Danes, clinical features, diagnosis, treatment, and prognosis. Acta Paediatr 87 8 (1998) 871-878
178. Duerr R.H. Genome-wide association studies herald a new era of rapid discoveries in inflammatory bowel disease research. Gastroenterology 132 5 (2007) 2045-2049
179. Van Limbergen J., Russell R.K., Nimmo E.R., et al. The genetics of inflammatory bowel disease. Am J Gastroenterol 102 12 (2007) 2820-2831
180. Mathew C.G. New links to the pathogenesis of Crohn's disease provided by genome-wide association scans. Nat Rev Genet 9 1 (2008) 9-14
181. Schreiber S., Rosenstiel P., Albrecht M., et al. Genetics of Crohn's disease, an archetypal inflammatory barrier disease. Nat Rev Genet 6 5 (2005) 376-388
182. Neurath M.F. IL-23: a master regulator in Crohn's disease. Nat Med 13 1 (2007) 26-28
183. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn's disease in ATG16L1. Nat Genet 39 2 (2007) 207-211
184. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 7 (2007) 830-832
185. Xavier R.J., and Podolsky D.K. Unraveling the pathogenesis of inflammatory bowel disease. Nature 448 7152 (2007) 427-434
186. Rarok A.A., van der Geld Y.M., Stegeman C.A., et al. Diversity of PR3-ANCA epitope specificity in Wegener's granulomatosis. Analysis using the biosensor technology. J Clin Immunol 23 6 (2003) 460-468
187. Gencik M., Meller S., Borgmann S., et al. Proteinase 3 gene polymorphisms and Wegener's granulomatosis. Kidney Int 58 6 (2000) 2473-2477
188. Pieters K., Pettersson A., Gullberg U., et al. The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity. Clin Exp Immunol 138 2 (2004) 266-270
189. Szyld P., Jagiello P., Csernok E., et al. On the Wegener's granulomatosis-associated region on chromosome 6p21.3. BMC Med Genet 7 (2006) 21-32
190. Jagiello P., Aries P., Arning L., et al. The PTPN22 620W allele is a risk factor for Wegener's granulomatosis. Arthritis Rheum 52 12 (2005) 4039-4043
191. Huang D., Giscombe R., Zhou Y., et al. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J Rheumatol 27 2 (2000) 397-401
192. Zhou Y., Huang D., Paris P.L., et al. An analysis of CTLA-4 and proinflammatory cytokine genes in Wegener's granulomatosis. Arthritis Rheum 50 8 (2004) 2645-2650
193. Muraközy G., Gaede K.I., Ruprecht B., et al. Gene polymorphisms of immunoregulatory cytokines and angiotensin-converting enzyme in Wegener's granulomatosis. J Mol Med 79 11 (2001) 665-670
194. Bartfai Z., Gaede K.I., Russell K.A., et al. Different gender-associated genotype risks of Wegener's granulomatosis and microscopic polyangiitis. Clin Immunol 109 3 (2003) 330-337
195. Zhou Y., Giscombe R., Huang D., et al. Novel genetic association of Wegener's granulomatosis with the interleukin 10 gene. J Rheumatol 29 2 (2002) 317-320
196. Seitzer U., Gerdes J., and Müller-Quernheim J. Genotyping in the MHC locus: potential for defining predictive markers in sarcoidosis. Respir Res 3 1 (2002) 6-12
197. Grutters J.C., Sato H., Welsh K.I., et al. The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 29 3 Suppl (2003) S59-S62
198. Gaede K.I., Kataria Y.P., Mamat U., et al. Analysis of differentially regulated mRNAs in monocytic cells induced by in vitro stimulation with Kveim-Siltzbach test reagent. Exp Lung Res 30 3 (2004) 181-192
199. Sato H., Spagnolo P., Silveira L., et al. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens 70 6 (2007) 480-486
200. Grunewald J., and Eklund A. Human leukocyte antigen genes may outweigh racial background when generating a specific immune response in sarcoidosis. Eur Respir J 17 5 (2001) 1046-1048
201. Takashige N., Naruse T.K., Matsumori A., et al. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis. Tissue Antigens 54 2 (1999) 191-193
202. Rutherford R.M., Kehren J., Staedtler F., et al. Functional genomics in sarcoidosis-reduced or increased apoptosis?. Swiss Med Wkly 131 31-32 (2001) 459-470
203. Thonhofer R., Maercker C., and Popper H.H. Expression of sarcoidosis related genes in lung lavage cells. Sarcoidosis Vasc Diffuse Lung Dis 19 1 (2002) 59-65
204. Sabounchi-Schutt F., Astrom J., Hellman U., et al. Changes in bronchoalveolar lavage fluid proteins in sarcoidosis: a proteomics approach. Eur Respir J 21 3 (2003) 414-420
205. Magi B., Bini L., Perari M.G., et al. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis 23 19 (2002) 3434-3444
206. Rottoli P., Magi B., Perari M.G., et al. Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Proteomics 5 5 (2005) 1423-1430
207. Wahlstrom J., Dengjel J., Persson B., et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Invest 117 11 (2007) 3576-3582